AU5142498A - Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction - Google Patents

Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction

Info

Publication number
AU5142498A
AU5142498A AU51424/98A AU5142498A AU5142498A AU 5142498 A AU5142498 A AU 5142498A AU 51424/98 A AU51424/98 A AU 51424/98A AU 5142498 A AU5142498 A AU 5142498A AU 5142498 A AU5142498 A AU 5142498A
Authority
AU
Australia
Prior art keywords
growth hormone
cardiac failure
hormone secretagogue
treating cardiac
vascular dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51424/98A
Inventor
Ferruccio BERTI
Muny Boghen
Vito DE GENNARO COLONNA
Eugenio Muller
Magnus Nilsson
Giuseppe ROSSONI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9604300A external-priority patent/SE9604300D0/en
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Publication of AU5142498A publication Critical patent/AU5142498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
AU51424/98A 1996-11-22 1997-11-21 Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction Abandoned AU5142498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9604300A SE9604300D0 (en) 1996-11-22 1996-11-22 Therapeutic use and method
SE9604300 1996-11-22
SE9703929 1997-10-28
SE9703929A SE9703929D0 (en) 1996-11-22 1997-10-28 Therapeutic use and method
PCT/SE1997/001957 WO1998022124A1 (en) 1996-11-22 1997-11-21 Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction

Publications (1)

Publication Number Publication Date
AU5142498A true AU5142498A (en) 1998-06-10

Family

ID=26662804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51424/98A Abandoned AU5142498A (en) 1996-11-22 1997-11-21 Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction

Country Status (3)

Country Link
AU (1) AU5142498A (en)
SE (1) SE9703929D0 (en)
WO (1) WO1998022124A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
US5932548A (en) * 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
US6025471A (en) * 1998-06-03 2000-02-15 Deghenghi; Romano Diazaspiro, azepino and azabicyclo therapeutic peptides
CA2352316A1 (en) * 1998-11-26 2000-06-02 Auckland Uniservices Limited Treatment of hypertension
WO2001097831A1 (en) 2000-06-23 2001-12-27 Kaken Pharmaceutical Co., Ltd. Preventives or remedies for heart failure
CU23157A1 (en) * 2001-01-03 2006-07-18 Ct Ingenieria Genetica Biotech PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TISSULAR DANE DUE TO LACK OF BLOOD IRRIGATION ARTERIAL
WO2004014412A1 (en) * 2002-08-09 2004-02-19 Kaken Pharmaceutical Co., Ltd. Myocardial cell protecting agents
WO2004017986A1 (en) * 2002-08-23 2004-03-04 Valorisation-Recherche, Societe En Commandite Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2005039625A1 (en) * 2003-10-28 2005-05-06 Rheoscience A/S Growth hormone secretagogue receptor agonists
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
WO2013190520A2 (en) * 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007578A1 (en) * 1990-10-25 1992-05-14 Genentech, Inc. Use of protective agents against reactive oxygen species

Also Published As

Publication number Publication date
SE9703929D0 (en) 1997-10-28
WO1998022124A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
PL327634A1 (en) Growth hormone secretion stimulating compounds
AU682414B2 (en) Stimulation of growth hormone responsive tissues
AU6319594A (en) Implantable lead having self-locking suture sleeve
AU2931997A (en) Treatment of mood disorders with a growth hormone secretagogue
AU5142498A (en) Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction
PL337654A1 (en) Substituted dipeptide tartrates as growth hormone stimulating agents
AU4033493A (en) Suture ring for heart valve prosthesis
PL338883A1 (en) Growth hormone secretion stimulating compounds
ZA977524B (en) Process for the preparation of bone cements comprising active compound.
AU2562797A (en) Combination therapy for treatment of erectile dysfunction
AU7545594A (en) Implantable device for the treatment of aedemas
AU9471598A (en) Treatment of congestive heart failure with growth hormone secretagogues
EP0669830A4 (en) Substituted dipeptide analogs promote release of growth hormone.
EP1137805A4 (en) Methods of facilitating vascular growth
AU7731894A (en) Implantable stimulation system and method for terminating cardiac arrhythmias
AU8534291A (en) Renal-selective angiotensin ii antagonists for treatment of hypertension
HU9402317D0 (en) Protein compound capable of inhibiting tumoral growth
GB9622440D0 (en) Treatment of congestive heart failure with a growth hormone secretagogue
AU3584093A (en) Diaminopyridine compounds for the inhibition of protein glycosylation
AU2969597A (en) Treatment of vascular lesions
AU7609298A (en) Treatment of heart failure with growth hormone
AU1942995A (en) New use of growth hormone
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
AU7854094A (en) Use of amiodarone for the treatment of heart failure
AU1401495A (en) Human vascular ibp-like growth factor